Scintigraphic detection of carcinoid tumors with a cost effectiveness analysis

World Journal of Gastroenterology

Volumn 10, Issue 24, 2004, Pages 3628-3633

  Dimitroulopoulos, Dimitris ^a,c   Xynopoulos, Dimitris ^a   Tsamakidis, Klisthenis ^a   Paraskevas, Emmanouel ^a   Zisimopoulos, Athanassios ^a   Andriotis, Efthymios ^a   Fotopoulou, Ekaterini ^a   Kontis, Marios ^a   Paraskevas, Ionnis ^b   Apostolikas, Nikiforos ^a  

^a Agios Savvas Cancer Hospital   (Greece)

^b CITY UNIVERSITY   (United Kingdom)

^c NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PENTETREOTIDE; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ECHOGRAPHY; FEMALE; GASTROINTESTINAL TRACT SCINTISCANNING; HEALTH CARE COST; HUMAN; INTERMETHOD COMPARISON; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS POTENTIAL; PANCREAS CANCER; PANCREAS SCINTISCANNING; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; THORAX RADIOGRAPHY;

EID: 10244226743     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i24.3628     Document Type: Article

References (36)

1. Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, Martin JB, Fauci S, Root RK (eds). Harrison's principles of internal medicine (12th ed), New york: McGraw Hill 1991
2. Pearse AG, Polak JM, Heath CM. Polypeptide hormone production by "carcinoid" apudomas and their relevant cytochemistry. Virchows Arch 1974; 16: 95-109
3. Vinik AI, McLeod MK, Fig LM, Shapiro B, Lloyd RV, Cho K. Clinical features, diagnosis and localization of carcinoid tumors and their management. Gastroenterol Clin N Am 1989; 18: 865-896
4. Janson ET, Oberg K. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon. Acta Oncol 1993; 2: 225-229
5. Godwin JD. Carcinoid tumors. An analysis of 2 837 cases. Cancer 1975; 36: 560-569
6. Moertel CG. Karnofsky memorial lecture: An odessey in the land of small tumors. J Clin Oncol1987; 10: 1502-1522
7. Kvols LK, Reubi JC. Metastatic carcinoid tumors and the malignant carcinoid syndrome. Acta Oncol 1993; 32: 197-201
8. Akerström G, Makridis C, Johansson H. Abdominal surgery in patients with midgut carcinoid tumors. Acta Oncol 1991; 30: 547-553
9. Krenning EP, Bakker WH, Breeman WA, Koper JW, Kooij PP, Ausoma L, Lameris JS, Reubi JC, Lamberts SW. Localization of endocrine-related tumors with radioiodinated analogue of somatostatin. Lancet 1989; 1: 242-244
10. Lamberts SW, Bakker WH, Reubi JC, Krenning EP. Somatostatin receptor imaging in the localization of endocrine tumors. N Engl J Med 1990; 323: 1246-1249
11. Reubi JC, Häcki WH, Lamberts SW. Hormone-producing gastro-intestinal tumors contain a high density of somatostatin receptors. J Clin Endocrinol Metab 1987; 65: 1127-1134
12. Reubl JC, Laissue J, Krenning E, Lamberts SW. Somatostatin receptors in human cancer: incidence, characteristics, functional correlates and clinical implications. J Steroid Biochem Mol Biol 1992; 43: 27-35
13. Reubi JC, Kvols L, Krenning E, Lamberts SW. Distribution of somatostatin receptors in normal and tumor tissue. Metabolism 1990; 39(Suppl 2): 78-81
14. Bakker WH, Krenning EP, Breeeman WA, Kooij PP, Reubi JC, Koper JW, de Jong M, Lameris JS, Visser TJ, Lamberts SW. In vivo use of a radioiodinated somatostatin analogue: dynamics, metabolism and binding to somatostatin receptor-positive tumors in man. J Nucl Med 1991; 32: 1184-1189
15. Bakker WH, Krenning EP, Breeman WA, Koper JW, Kooij PP, Reubi JC, Klijn JG, Visser TJ, Docter R, Lamberts SW. Receptor scintigraphy with a radioiodinated somatostatin analogue: radiolabeling, purification, biologic activity and in vivo application in animals. J Nucl Med 1990; 31: 1501-1509
16. Joseph K, Stapp J, Reinecke J, Hoffken H, Benning R, Neuhaus C, Trautmmm ME, Schwerk WB, Arnold R. Rezeptorszintigraphic bei endokrinen gastroenteropankreatischen tumoren. Dtsch Med Wschr 1992; 117: 1025-1028
17. 3]. Eur J Nucl Med 1993; 20: 716-731
18. Kvols L. Somatostatin-receptor imaging of human malignancies: a new era in the localization, staging and treatment of tumors. Gastroenterology 1993; 105: 1909-1914
19. Nash SV, Said JW. Gastroenteropancreatic neuroendocrine tumors: a histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut and hindgut tumors. Am J Clin Pathol 1986; 86: 415-422
20. Simpson S, Vinik AI, Marangos PJ, Lloyd RV. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum level of neuron-specific enolase. Cancer 1984; 54: 1364-1369
21. Zimmer T, Ziegler K, Bader M, Fett U, Hamm B, Riecken EO, Wiedenmann B. Localization of neuroendocrine tumors of the upper gastrointestinal tract. Gut 1994; 35: 471-475
22. Picus D, Glazer HS, Levitt RG, Husband JE. Computed tomography of abdominal carcinoid tumors. Am J Roentgenol 1984; 143: 581-584
23. McCarthy SM, Stark DD, Moss AA, Goldberg HI. Computed tomography of malignant carcinoid disease. J Comput Assist Tomogr 1984; 8: 846-850
24. Kressel HY. Strategies for magnetic resonance imaging of focal liver disease. Radiol Clin North Am 1988; 26: 607-617
25. Kisker O, Weinel RJ, Geks J, Zacara F, Joseph K, Rothmund M. Value of somatostatin receptor scintigraphy for preoperative localization of carcinoids. World J Surg 1996; 20: 162-167
26. 111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MRI imaging. QJM ,1998; 91: 295-301
27. de Herder WW, Lamberts SW. Somatostatin and somatostatin analogues: diagnostic and therapeutic uses. Curr Opin Oncol 2002; 14: 53-57
28. Tomassetti P, Migliori M, Lalli S, Campana D, Tomassetti V, Corinaldesi R. Epidemiology, clinical features and diagnosis of gastroenteropancreatic endocrine tumors. Ann Oncol 2001; 12: s95-s99
29. Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 1990; 50: 5969-5977
30. Reisine T, Bell GI. Molecular biology of somatostatin receptors. Endocri Rev 1995; 16: 427-442
31. Kwekkeboom DJ, Krenning EP, Bakker WH, Oei HY, Kooij PP, Lamberts SW. Somatostatin analogue scintigraphy in carcinoid tumors. Eur J Nucl Med 1993; 20: 283-292
32. Carnaille B, Nocaudie M, Pattou F, Huglo D, Deveaux M, Marchandise X, Proge C. Scintiscans and carcinoid-tumors. Surgery 1994; 116: 1118-1122
33. Scherubl H, Bader M, Fett U, Hamm B, Schmidt-Gayk H, Koppenhagen K, Dop FJ, Riecken EO, Wiedemann B. Somatostatin-receptor imaging of neuroendocrine gastroenteropacreatic tumors. Gastroenterology 1993; 105: 1705-1709
34. Lebtahi R, Cadiot G, Sarda L, Daou D, Faraggi M, Petegnief Y, Mignon M, Le Guludec D. Clinical impact of Somatostatin receptor scintigraphy in the management of patients with neuroendocrine gastroenteropancreatic tumors. J Nucl Med 1997; 38: 853-858
35. Schillaci O, Scopinaro F, Angeletti S, Tavolaro R, Danieli R, Annibale B, Gualdi G, Delle Fave G. SPECT improves accuracy of somatostatin receptor scintigraphy in abdominal carcinoid tumors. J Nucl Med 1996; 37: 1452-1456
36. Kwekkeboom DJ, Lamberts SW, Habbema JD, Krenning EP. Cost-effectiveness analysis of somatostatin receptor scintigraphy. J Nucl Med 1996; 37: 886-892